Dr Reddy’s Laboratories receives USFDA EIR for Srikakulam facility after GMP and PAI inspection, strengthening regulatory compliance and global pharma manufacturing credibility.
Fujifilm India has launched endoscopy manufacturing in Jodhpur, marking a major step toward local production of advanced medical devices. The move supports Make in India and aims to improve access to diagnostic technology.
Alembic Pharmaceuticals achieves a milestone with the prescription-based sale of Pivya, a first-line oral antibiotic for UTI treatment, marking a key growth in global markets.
Novo Nordisk’s blockbuster diabetes drug is set to reshape India’s pharma market as the semaglutide patent expiry approaches. More than 50 companies are preparing generic versions, triggering a major race in the obesity and diabetes drug segment.
Gland Pharma receives USFDA tentative approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%, expanding its ophthalmic portfolio and strengthening its US market presence.
India’s pharmaceutical industry may face export disruptions worth up to ?5,000 crore as escalating conflict in West Asia affects shipping routes, raises freight costs, and threatens supply chains for medicines and raw materials.
.png "India Proposes Biomanufacturing Working Group With Delaware")
India is stepping up its biomanufacturing ambitions by proposing a new working group with Delaware to boost collaboration in research, startups, and advanced biologics manufacturing.
Aurobindo Pharma’s subsidiary, Eugia Pharma, has launched Pomalidomide Capsules in the U.S., targeting the $3.3?billion oncology and specialty drug market.
A new study shows laser treatment before immunotherapy could help patients with aggressive brain tumors live longer.
Glenmark plans to launch affordable semaglutide in India, competing with major players like Sun Pharma and Dr. Reddy’s. Aiming to revolutionize the anti-diabetes market.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")